Mikhail Kosiborod

Dr. Kosiborod is a cardiologist and Director of Cardiometabolic Research Group at Saint Luke’s Mid America Heart Institute, and Professor of Medicine at the University of Missouri-Kansas City. He received clinical training in internal medicine and cardiovascular disease at Yale University School of Medicine, and training in clinical research and epidemiology through the Robert Wood Johnson Clinical Scholars Program. Dr. Kosiborod is an internationally recognized expert in the fields of diabetes and cardiovascular disease, cardiometabolic and cardiorenal syndromes, as well as quality of care and outcomes. He has authored and co-authored over 130 peer-reviewed publications, including scientific statements and position documents. He is involved in many clinical trials, both in the leadership role, as well as principal investigator at Saint Luke’s Mid America Heart Institute.
Dr. Kosiborod is actively involved in the work of multiple committees for the American College of Cardiology and American Heart Association, and currently chairs the ACC/ADA/ACP/Joslyn Diabetes Collaborative Registry Steering Committee, the American Heart Association’s Quality of Care and Outcomes Research Conference, and is the immediate past chair of the American Heart Association Diabetes Committee. He serves on the editorial boards of several scientific journals, including Journal of the American College of Cardiology and Circulation. Dr. Kosiborod is closely involved in mentoring many trainees– both locally and across other institutions nationally and internationally.